Drug Transporter (DT) Information

General Information of DT
DT ID DTD0418
Gene Name SLC5A1
Protein Name Sodium/glucose cotransporter 1
Gene ID
6523
UniProt ID
P13866
TCDB ID
2.A.21.3.1
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 2XQ2_A

Identity: 30.556%

Minimized Score: -991.414 kcal/mol

Detail: Structure Info

Synonyms D22S675; High affinity sodium-glucose cotransporter; NAGT; Na(+)/glucose cotransporter 1; SGLT1; SLC5A1; Solute carrier family 5 member 1
DT Family Solute:Sodium Symporter (SSS) Family ;
Tissue Specificity Expressed mainly in intestine and kidney.
Function This transporter actively transports glucose into cells by Na(+) cotransport with a Na(+) to glucose coupling ratio of 2:1.
Endogenous Substrate(s) Galactose; Na+; Water
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Clinical Trial Drug

 Click to Show/Hide the Full List of Drug:            2 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
2-Deoxyglucose
 Phase 1/2 Drug Info Cancer 2A00-2F9Z [1]
Fucose
 Phase 1/2 Drug Info Type 2 leukocyte adhesion deficiency 5C54.2 [1]
References
1 The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing. PLoS One. 2014 Feb 26;9(2):e89977.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.